Literature DB >> 21712795

Methods to assess beta cell death mediated by cytotoxic T lymphocytes.

Jing Chen1, Scott Grieshaber, Clayton E Mathews.   

Abstract

Type 1 diabetes (T1D) is a T cell mediated autoimmune disease. During the pathogenesis, patients become progressively more insulinopenic as insulin production is lost, presumably this results from the destruction of pancreatic beta cells by T cells. Understanding the mechanisms of beta cell death during the development of T1D will provide insights to generate an effective cure for this disease. Cell-mediated lymphocytotoxicity (CML) assays have historically used the radionuclide Chromium 51 ((51)Cr) to label target cells. These targets are then exposed to effector cells and the release of (51)Cr from target cells is read as an indication of lymphocyte-mediated cell death. Inhibitors of cell death result in decreased release of (51)Cr. As effector cells, we used an activated autoreactive clonal population of CD8(+) Cytotoxic T lymphocytes (CTL) isolated from a mouse stock transgenic for both the alpha and beta chains of the AI4 T cell receptor (TCR). Activated AI4 T cells were co-cultured with (51)Cr labeled target NIT cells for 16 hours, release of (51)Cr was recorded to calculate specific lysis Mitochondria participate in many important physiological events, such as energy production, regulation of signaling transduction, and apoptosis. The study of beta cell mitochondrial functional changes during the development of T1D is a novel area of research. Using the mitochondrial membrane potential dye Tetramethyl Rhodamine Methyl Ester (TMRM) and confocal microscopic live cell imaging, we monitored mitochondrial membrane potential over time in the beta cell line NIT-1. For imaging studies, effector AI4 T cells were labeled with the fluorescent nuclear staining dye Picogreen. NIT-1 cells and T cells were co-cultured in chambered coverglass and mounted on the microscope stage equipped with a live cell chamber, controlled at 37°C, with 5% CO(2;), and humidified. During these experiments images were taken of each cluster every 3 minutes for 400 minutes. Over a course of 400 minutes, we observed the dissipation of mitochondrial membrane potential in NIT-1 cell clusters where AI4 T cells were attached. In the simultaneous control experiment where NIT-1 cells were co-cultured with MHC mis-matched human lymphocyte Jurkat cells, mitochondrial membrane potential remained intact. This technique can be used to observe real-time changes in mitochondrial membrane potential in cells under attack of cytotoxic lymphocytes, cytokines, or other cytotoxic reagents.

Entities:  

Mesh:

Year:  2011        PMID: 21712795      PMCID: PMC3217247          DOI: 10.3791/2724

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

Review 1.  The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update.

Authors:  J D Ly; D R Grubb; A Lawen
Journal:  Apoptosis       Date:  2003-03       Impact factor: 4.677

2.  NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse.

Authors:  K Hamaguchi; H R Gaskins; E H Leiter
Journal:  Diabetes       Date:  1991-07       Impact factor: 9.461

Review 3.  Pathophysiology of immune-mediated (type 1) diabetes mellitus: potential for immunotherapy.

Authors:  M Abel; M Krokowski
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

Review 4.  Imaging of mitochondrial polarization and depolarization with cationic fluorophores.

Authors:  John J Lemasters; Venkat K Ramshesh
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

5.  Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways.

Authors:  Nadine L Dudek; Helen E Thomas; Lina Mariana; Robyn M Sutherland; Janette Allison; Eugene Estella; Eveline Angstetra; Joseph A Trapani; Pere Santamaria; Andrew M Lew; Thomas W H Kay
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

6.  Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives.

Authors:  R C Scaduto; L W Grotyohann
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

Review 7.  Mitochondria mediated cell death in diabetes.

Authors:  Gyorgy Szabadkai; Michael R Duchen
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

8.  Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

Authors:  C E Mathews; R T Graser; A Savinov; D V Serreze; E H Leiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell.

Authors:  Jing Chen; Aaron M Gusdon; Jon Piganelli; Edward H Leiter; Clayton E Mathews
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

10.  In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

Authors:  S V Pakala; M Chivetta; C B Kelly; J D Katz
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

  10 in total
  7 in total

1.  Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.

Authors:  John P Driver; Jeremy J Racine; Cheng Ye; Deanna J Lamont; Brittney N Newby; Caroline M Leeth; Harold D Chapman; Todd M Brusko; Yi-Guang Chen; Clayton E Mathews; David V Serreze
Journal:  Diabetes       Date:  2016-12-05       Impact factor: 9.461

2.  Innate inflammation drives NK cell activation to impair Treg activity.

Authors:  Joseph W Dean; Leeana D Peters; Christopher A Fuhrman; Howard R Seay; Amanda L Posgai; Scott E Stimpson; Maigan A Brusko; Daniel J Perry; Wen-I Yeh; Brittney N Newby; Michael J Haller; Andrew B Muir; Mark A Atkinson; Clayton E Mathews; Todd M Brusko
Journal:  J Autoimmun       Date:  2020-02-06       Impact factor: 7.094

3.  The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice.

Authors:  Robert L Whitener; Lisa Gallo Knight; Jianwei Li; Sarah Knapp; Shuyao Zhang; Mani Annamalai; Vadim M Pliner; Dongtao Fu; Ilian Radichev; Christina Amatya; Alexei Savinov; Arif Yurdagul; Shuai Yuan; John Glawe; Christopher G Kevil; Jing Chen; Scott E Stimpson; Clayton E Mathews
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

4.  Utilization of fluorescent probes for the quantification and identification of subcellular proteomes and biological processes regulated by lipid peroxidation products.

Authors:  Timothy D Cummins; Ashlee N Higdon; Philip A Kramer; Balu K Chacko; Daniel W Riggs; Joshua K Salabei; Louis J Dell'Italia; Jianhua Zhang; Victor M Darley-Usmar; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2012-08-23       Impact factor: 7.376

5.  Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway.

Authors:  Brittney N Newby; Todd M Brusko; Baiming Zou; Mark A Atkinson; Michael Clare-Salzler; Clayton E Mathews
Journal:  Diabetes       Date:  2017-09-06       Impact factor: 9.461

Review 6.  T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Authors:  Adam L Burrack; Tijana Martinov; Brian T Fife
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-05       Impact factor: 5.555

7.  Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes.

Authors:  Lucas H Armitage; Scott E Stimpson; Katherine E Santostefano; Lina Sui; Similoluwa Ogundare; Brittney N Newby; Roberto Castro-Gutierrez; Mollie K Huber; Jared P Taylor; Prerana Sharma; Ilian A Radichev; Daniel J Perry; Natalie C Fredette; Alexei Y Savinov; Mark A Wallet; Naohiro Terada; Todd M Brusko; Holger A Russ; Jing Chen; Dieter Egli; Clayton E Mathews
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-09       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.